Zacks Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-35,915
| Closed | -$105K | – | 592 |
|
|
2020
Q2 | $105K | Buy |
35,915
+17,995
| +100% | +$52.6K | ﹤0.01% | 489 |
|
|
2020
Q1 | $51K | Buy |
+17,920
| New | +$51K | ﹤0.01% | 481 |
|
|
2019
Q3 | – | Sell |
-29,324
| Closed | -$92K | – | 622 |
|
|
2019
Q2 | $92K | Sell |
29,324
-88,055
| -75% | -$276K | ﹤0.01% | 516 |
|
|
2019
Q1 | $437K | Buy |
+117,379
| New | +$437K | 0.01% | 465 |
|
|
2015
Q1 | – | Sell |
-28,621
| Closed | -$221K | – | 788 |
|
|
2014
Q4 | $221K | Buy |
+28,621
| New | +$221K | 0.01% | 578 |
|